-       Report 
   - April 2024
    -  132 Pages 
    Global
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - January 2024
    -  132 Pages 
    Global
   
   From       €854EUR$950USD£749GBP 
                -       Report 
   - November 2021
    -  1032 Pages 
    Global
   
   From       €4494EUR$5,000USD£3,941GBP 
                                 The Cardiac Marker market is a segment of the Pharmaceuticals industry that focuses on the development and production of drugs and other treatments for cardiovascular diseases. Cardiac markers are substances that are released into the bloodstream when the heart is damaged or stressed. These markers can be used to diagnose and monitor the progression of cardiovascular diseases, such as heart attack, stroke, and congestive heart failure. The market is driven by the increasing prevalence of    cardiovascular diseases, the growing demand for early diagnosis and treatment, and the development of new technologies.
The Cardiac Marker market is highly competitive, with a number of large and small companies operating in the space. Some of the major players in the market include Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less   Read more